Advocacy Wealth Management Services’s Puma Biotechnology PBYI Stock Holding History

Advocacy Wealth Management Services’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-200	Closed	-$4K	–	164
2018 Q4	$4K	Hold	200	–	–	﹤0.01%	142
2018 Q3	$9K	Hold	200	–	–	0.01%	136
2018 Q2	$12K	Hold	200	–	–	0.01%	119
2018 Q1	$14K	Hold	200	–	–	0.01%	113
2017 Q4	$20K	Hold	200	–	–	0.01%	109
2017 Q3	$24K	Hold	200	–	–	0.01%	119
2017 Q2	$17K	Hold	200	–	–	0.01%	150
2017 Q1	$7K	Hold	200	–	–	﹤0.01%	240
2016 Q4	$6K	Hold	200	–	–	﹤0.01%	242
2016 Q3	$13K	Buy	+200	New	+$10.1K	0.01%	247

Other funds holding PBYI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Federated Hermes

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return